The Nigerian pharmaceutical industry is gradually dying. The imminent death of this sector arises from the ill-advised Common External Tariff (CET) regime, which places zero duty on imported finished drugs but imposes between five and 20 percent tariffs on raw and packaging materials.
This sector i
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
ODINAKA ANUDU
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more